Published in
Springer Verlag, PharmacoEconomics, 3(37), p. 333-343, 2018
DOI: 10.1007/s40273-018-0713-7
Links
Tools
Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Journal article published in 2018 by
Paul Tappenden 
,
Emma Simpson,
Jean Hamilton,
Daniel Pollard ,
Mark Clowes,
Eva Kaltenthaler,
David Meiklejohn,
Nick Morley
,
Emma Simpson,
Jean Hamilton,
Daniel Pollard ,
Mark Clowes,
Eva Kaltenthaler,
David Meiklejohn,
Nick Morley
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 